Question

A 58-year-old with chronic HFrEF (LVEF 25%) presents for optimization. He is euvolemic on sacubitril/valsartan, metoprolol succinate, and furosemide. eGFR is 55 mL/min/1.73 m², K⁺ 4.6 mEq/L, BP 118/72 mm Hg. Which additional therapy best reduces mortality and HF hospitalization now?

Accepted Answer

Start spironolactone 25 mg daily

Answer

metoprolol succinate

Answer

and furosemide. eGFR is 55 mL/min/1.73 m²

Answer

K⁺ 4.6 mEq/L

Answer

BP 118/72 mm Hg. Which additional therapy best reduces mortality and HF hospitalization now?

Practice question

A 58-year-old with chronic HFrEF (LVEF 25%) presents for optimization. He is euvolemic on sacubitril/valsartan, metoprolol succinate, and furosemide. eGFR is 55 mL/min/1.73 m², K⁺ 4.6 mEq/L, BP 118/72 mm Hg. Which additional therapy best reduces mortality and HF hospitalization now?